EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC-SA 4.0

Pharmacokinetically guided Pre-dialytic Administration of Amikacin in a Haemodialysis Patient with Resistant Infections: A CARE-compliant Case Report

Soo Piing Chew, Suzana Mustafa

Asian Journal of Medicine & Health Sciences · 29.10.2026 · 9 (2)

DOI: 10.70672/rv0qnf80 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Asian Journal of Medicine & Health Sciences, online erschienen am 29.10.2026. Verfasst von Soo Piing Chew und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Managing carbapenem-resistant Enterobacterales (CRE) in haemodialysis patients is challenging due to the narrow therapeutic index of aminoglycosides. We report a case of a 59-year-old Malaysian male with end-stage renal disease (ESRD) and a severe CRE Klebsiella pneumoniae infection who was managed with a pharmacokinetically guided pre-dialytic amikacin strategy. Case Presentation: The patient initially failed conventional post-dialysis dosing, resulting in sub-therapeutic peaks and a toxic trough of 15 µg/mL. We switched to a pre-dialytic regimen (6–7 mg/kg), utilising high-flux dialysis as a "controlled clearance" mechanism. This achieved a bactericidal Cmax of 29.6 µg/mL, a safe trough of 9.2 µg/mL, and average AUC24 ranging from 332-399.8 mg.h/L. The patient tolerated extended pre-dialysis drug exposure of up to 10.5 hours without clinically apparent ototoxicity. However, the patient was readmitted at Day 65 with septic shock and died at Day 82; this death was not attributed to amikacin toxicity.

Conclusion

This case suggests that pre-dialytic dosing may provide a safe, operationally flexible method to achieve critical pharmacokinetic/pharmacodynamic (PK/PD) targets (Cmax/MIC 8-10) in complex CRE infections, warranting further investigation in larger studies.

Zitieren

APA

Chew, S. P., & Mustafa, S. (2026). Pharmacokinetically guided Pre-dialytic Administration of Amikacin in a Haemodialysis Patient with Resistant Infections: A CARE-compliant Case Report. Asian Journal of Medicine & Health Sciences, 9(2). https://doi.org/10.70672/rv0qnf80

Vancouver

Chew SP, Mustafa S. Pharmacokinetically guided Pre-dialytic Administration of Amikacin in a Haemodialysis Patient with Resistant Infections: A CARE-compliant Case Report. Asian Journal of Medicine & Health Sciences. 2026;9(2). doi:10.70672/rv0qnf80

BibTeX
@article{Chew2026,
  author = {Chew, Soo Piing and Mustafa, Suzana},
  title = {Pharmacokinetically guided Pre-dialytic Administration of Amikacin in a Haemodialysis Patient with Resistant Infections: A CARE-compliant Case Report},
  journal = {Asian Journal of Medicine & Health Sciences},
  year = {2026},
  volume = {9},
  number = {2},
  doi = {10.70672/rv0qnf80}
}
Kostenlos starten →